Cargando…

Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation

BACKGROUND: The A53T mutation in the α-synuclein gene causes autosomal-dominant Lewy body Parkinson's disease (PD). Cultured cell models have linked this mutation to increased cell macroautophagy, although evidence of enhanced macroautophagy in patients with this mutation has not been assessed....

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yue, Chegini, Fariba, Chua, Germaine, Murphy, Karen, Gai, Weiping, Halliday, Glenda M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506995/
https://www.ncbi.nlm.nih.gov/pubmed/23210740
http://dx.doi.org/10.1186/2047-9158-1-2
_version_ 1782250992942710784
author Huang, Yue
Chegini, Fariba
Chua, Germaine
Murphy, Karen
Gai, Weiping
Halliday, Glenda M
author_facet Huang, Yue
Chegini, Fariba
Chua, Germaine
Murphy, Karen
Gai, Weiping
Halliday, Glenda M
author_sort Huang, Yue
collection PubMed
description BACKGROUND: The A53T mutation in the α-synuclein gene causes autosomal-dominant Lewy body Parkinson's disease (PD). Cultured cell models have linked this mutation to increased cell macroautophagy, although evidence of enhanced macroautophagy in patients with this mutation has not been assessed. OBJECTIVE: To determine whether macroautophagy is increased by the A53T α-synuclein gene mutation in PD patients and cell models. METHODS: Formalin-fixed paraffin-embedded 10 μm-thick tissue sections from the substantia nigra and anterior cingulate cortex of two PD patients with the A53T α-synuclein gene mutation were compared with four sporadic PD cases and four controls obtained from the Sydney Brain Bank. Lewy bodies were isolated from frontal cortex of a case with late stage PD (recruited from South Australian Brain Bank). Immunohistochemistry was performed for α-synuclein and the macroautophagy markers autophagy-specific gene (ATG) 5, ATG6/Beclin1 and ATG8/LC3. SH-SY5Y cells were transfected with wild type or A53T mutant α-synuclein plasmids and observable changes in macroautophagy marker protein levels assessed using Western blotting. RESULTS: α-Synuclein immunoreactive neurites and dots were more numerous in patients with A53T mutations compared with late stage sporadic PD patients, and perinuclear cytoplasmic α-synuclein aggregates were observed in the α-synuclein A53T gene transfected SH-SY5Y cells compared to wild type transfections. All PD patients (with or without A53T mutations) had increased immunohistochemical evidence for macroautophagy compared with controls, and the levels of the ATG5 complex were equally increased in wild type and A53T α-synuclein gene transfected cells compared to controls. CONCLUSION: Despite increased α-synuclein accumulation with A53T mutations, macroautophagy is not increased above that observed in sporadic patients with PD or in cells transfected with wild type α-synuclein, suggesting that mutated α-synuclein protein is not removed by macroautophagy.
format Online
Article
Text
id pubmed-3506995
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35069952012-11-29 Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation Huang, Yue Chegini, Fariba Chua, Germaine Murphy, Karen Gai, Weiping Halliday, Glenda M Transl Neurodegener Research BACKGROUND: The A53T mutation in the α-synuclein gene causes autosomal-dominant Lewy body Parkinson's disease (PD). Cultured cell models have linked this mutation to increased cell macroautophagy, although evidence of enhanced macroautophagy in patients with this mutation has not been assessed. OBJECTIVE: To determine whether macroautophagy is increased by the A53T α-synuclein gene mutation in PD patients and cell models. METHODS: Formalin-fixed paraffin-embedded 10 μm-thick tissue sections from the substantia nigra and anterior cingulate cortex of two PD patients with the A53T α-synuclein gene mutation were compared with four sporadic PD cases and four controls obtained from the Sydney Brain Bank. Lewy bodies were isolated from frontal cortex of a case with late stage PD (recruited from South Australian Brain Bank). Immunohistochemistry was performed for α-synuclein and the macroautophagy markers autophagy-specific gene (ATG) 5, ATG6/Beclin1 and ATG8/LC3. SH-SY5Y cells were transfected with wild type or A53T mutant α-synuclein plasmids and observable changes in macroautophagy marker protein levels assessed using Western blotting. RESULTS: α-Synuclein immunoreactive neurites and dots were more numerous in patients with A53T mutations compared with late stage sporadic PD patients, and perinuclear cytoplasmic α-synuclein aggregates were observed in the α-synuclein A53T gene transfected SH-SY5Y cells compared to wild type transfections. All PD patients (with or without A53T mutations) had increased immunohistochemical evidence for macroautophagy compared with controls, and the levels of the ATG5 complex were equally increased in wild type and A53T α-synuclein gene transfected cells compared to controls. CONCLUSION: Despite increased α-synuclein accumulation with A53T mutations, macroautophagy is not increased above that observed in sporadic patients with PD or in cells transfected with wild type α-synuclein, suggesting that mutated α-synuclein protein is not removed by macroautophagy. BioMed Central 2012-01-13 /pmc/articles/PMC3506995/ /pubmed/23210740 http://dx.doi.org/10.1186/2047-9158-1-2 Text en Copyright ©2012 Huang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Huang, Yue
Chegini, Fariba
Chua, Germaine
Murphy, Karen
Gai, Weiping
Halliday, Glenda M
Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
title Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
title_full Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
title_fullStr Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
title_full_unstemmed Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
title_short Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
title_sort macroautophagy in sporadic and the genetic form of parkinson's disease with the a53t α-synuclein mutation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506995/
https://www.ncbi.nlm.nih.gov/pubmed/23210740
http://dx.doi.org/10.1186/2047-9158-1-2
work_keys_str_mv AT huangyue macroautophagyinsporadicandthegeneticformofparkinsonsdiseasewiththea53tasynucleinmutation
AT cheginifariba macroautophagyinsporadicandthegeneticformofparkinsonsdiseasewiththea53tasynucleinmutation
AT chuagermaine macroautophagyinsporadicandthegeneticformofparkinsonsdiseasewiththea53tasynucleinmutation
AT murphykaren macroautophagyinsporadicandthegeneticformofparkinsonsdiseasewiththea53tasynucleinmutation
AT gaiweiping macroautophagyinsporadicandthegeneticformofparkinsonsdiseasewiththea53tasynucleinmutation
AT hallidayglendam macroautophagyinsporadicandthegeneticformofparkinsonsdiseasewiththea53tasynucleinmutation